Home › Remedy Pharmaceuticals Announces Contest To Name Its Subarachnoid Hemorrhage Clinical Trial
 

Keywords :   


Remedy Pharmaceuticals Announces Contest To Name Its Subarachnoid Hemorrhage Clinical Trial

2016-06-08 04:14:03| drugdiscoveryonline News Articles

Remedy Pharmaceuticals, a privately-held pharmaceutical company focused on bringing life-saving hospital-based treatment to people affected by central nervous system (CNS) related edema, recently announced a contest to name its upcoming clinical trial in Subarachnoid Hemorrhage (SAH)

Tags: trial clinical contest announces

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
13.05HigherDoses New Red Light Hat Gives Hair Growth the Green Light
13.05Naturium Launches Glow Getter Body Oil Ahead of Summer 2024
13.05Aptoide sells stake in Faurecia Aptoide Automotive
13.05AppleTV+ fastest growing major SVOD service in Q1'24
13.05SafeShark finds connected devices not compliant with UK security law
13.05Zattoo deploys Bitmovin Player
13.05Altice USA residential video RGUs down 77,700 in 1Q 2024
13.05Fubo unveils new CTV ad offerings at 2024 IAB NewFronts
More »